RESTAGE (REPURPOSING STATINS TO IMPROVE OUTCOMES IN GASTROESOPHAGEAL CANCER) TRIAL: A PHASE II RANDOMIZED OPEN-LABEL TRIAL OF PERIOPERATIVE SIMVASTATIN PLUS STANDARD-OF-CARE SYSTEMIC THERAPY IN GASTROESOPHAGEAL ADENOCARCINOMA

Registry ID

THOR-ESO-2026-01

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE

Last update

2026-05-19

Conditions

• GASTRO-OESOPHAGEAL CANCER
• GASTROESOPHAGEAL ADENOCARCINOMA

Related clinical trials

• AACR ADAPTIVE BIOMARKER-DRIVEN ORGAN PRESERVATION TRIAL IN GASTROESOPHAGEAL ADENOCARCINOMAS
• ROSETTA GASTRIC-204: A BLINDED, RANDOMIZED, PHASE 2/3 STUDY OF PUMITAMIG IN COMBINATION WITH CHEMOTHERAPY VERSUS NIVOLUMAB IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH PREVIOUSLY UNTREATED ADVANCED OR METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, OR ESOPHAGEAL ADENOCARCINOMA
• A PHASE III, MULTICENTRE, RANDOMISED CONTROLLED STUDY OF SONESITATUG VEDOTIN IN COMBINATION WITH FLUOROPYRIMIDINE WITH OR WITHOUT RILVEGOSTOMIG IN FIRST-LINE CLAUDIN18.2-POSITIVE, HER2-NEGATIVE, ADVANCED/METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, OR ESOPHAGEAL ADENOCARCINOMA (CLARITY-GASTRIC 02)
• A MASTER PROTOCOL FOR AN OPEN-LABEL, MULTI-DRUG, MULTI-CENTER, PHASE II PLATFORM STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTI-TUMOR ACTIVITY OF NOVEL AGENTS OR COMBINATIONS AS PERIOPERATIVE TREATMENT IN PARTICIPANTS WITH LOCALLY ADVANCED RESECTABLE GASTROESOPHAGEAL ADENOCARCINOMA (GEMINI-PERIOP GC)
• BEAMION PANTUMOR-1: A PHASE II, MULTICENTRE, MULTICOHORT, OPEN LABEL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZONGERTINIB (BI 1810631) FOR THE TREATMENT OF SELECTED HER2-MUTATED OR OVEREXPRESSED/AMPLIFIED SOLID TUMOURS
• A PHASE 3, MULTICENTER, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF MK-2870 VERSUS TREATMENT OF PHYSICIAN¿S CHOICE IN 3L+ ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA (GASTRIC ADENOCARCINOMA, GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, AND ESOPHAGEAL ADENOCARCINOMA)

View on source registry